M. Dastjerdi a, Z. Abassi Radmoghadam a,b, M. Valadbeigi a, A. Dastjerdi a, F. Nasiri a, S. Akbari a,b,c, A. Akbari c aNanoSciTec GmbH, Hermann Weinhauser str. 67, Munich, 81867, Germany b BioMedEx GmbH, weyringerg 37 Stiege 1, 1040, Wein, Austria c GreenNanoTech Kft, Westend Business Center, 22-24 Váci street, Budapest, 1132, Hungary Abstract The…
DetailsNew research offers hope for more effective treatment options for peritoneal cancer. Scientists have discovered that nanotechnology can enhance the effectiveness of chemotherapy in combating this type of cancer. Astrid Hyldbakk, a researcher at SINTEF Industry in Biotechnology and Nanomedicine, explains that peritoneal cancer is challenging to detect, often leading to late diagnoses and ineffective…
DetailsA. Ghafari a,b, E. Mohammadi a, M. Dastjerdi a,b, S. Honarmand a Z. Abassi Radmoghadam a, S. Akbari a,b,c aNanoSciTec GmbH, Hermann Weinhauser str. 67, Munich, 81867, Germany b BioMedEx GmbH, weyringerg 37 Stiege 1, 1040, Wein, Austria c GreenNanoTech Kft, Westend Business Center, 22-24…
DetailsScientists at the University of Toronto have developed a new theory that explains how nanoparticles enter and exit tumors, potentially challenging the current understanding of cancer nanomedicine that has guided research for nearly four decades. The prevailing theory, known as the Enhanced Permeability and Retention (EPR) effect, suggests that nanoparticles enter tumors through gaps in…
Details
